Global Neurogenetic Testing Market Research Report 2024(Status and Outlook)
Report Overview:
Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.
The Global Neurogenetic Testing Market Size was estimated at USD 527.69 million in 2023 and is projected to reach USD 1030.46 million by 2029, exhibiting a CAGR of 11.80% during the forecast period.
This report provides a deep insight into the global Neurogenetic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurogenetic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurogenetic Testing market in any manner.
Global Neurogenetic Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Quest Diagnostics
Mayo Clinic
GeneDx
Illumina
Labcorp
Invitae
MedGenome Labs
Connecticut Children’s
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Market Segmentation (by Type)
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Market Segmentation (by Application)
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurogenetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.
The Global Neurogenetic Testing Market Size was estimated at USD 527.69 million in 2023 and is projected to reach USD 1030.46 million by 2029, exhibiting a CAGR of 11.80% during the forecast period.
This report provides a deep insight into the global Neurogenetic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurogenetic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurogenetic Testing market in any manner.
Global Neurogenetic Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Quest Diagnostics
Mayo Clinic
GeneDx
Illumina
Labcorp
Invitae
MedGenome Labs
Connecticut Children’s
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Market Segmentation (by Type)
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Market Segmentation (by Application)
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neurogenetic Testing Market
- Overview of the regional outlook of the Neurogenetic Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurogenetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neurogenetic Testing
1.2 Key Market Segments
1.2.1 Neurogenetic Testing Segment by Type
1.2.2 Neurogenetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROGENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROGENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Neurogenetic Testing Revenue Market Share by Company (2019-2024)
3.2 Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Neurogenetic Testing Market Size Sites, Area Served, Product Type
3.4 Neurogenetic Testing Market Competitive Situation and Trends
3.4.1 Neurogenetic Testing Market Concentration Rate
3.4.2 Global 5 and 10 Largest Neurogenetic Testing Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 NEUROGENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Neurogenetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROGENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROGENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurogenetic Testing Market Size Market Share by Type (2019-2024)
6.3 Global Neurogenetic Testing Market Size Growth Rate by Type (2019-2024)
7 NEUROGENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurogenetic Testing Market Size (M USD) by Application (2019-2024)
7.3 Global Neurogenetic Testing Market Size Growth Rate by Application (2019-2024)
8 NEUROGENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Neurogenetic Testing Market Size by Region
8.1.1 Global Neurogenetic Testing Market Size by Region
8.1.2 Global Neurogenetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Neurogenetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurogenetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurogenetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurogenetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurogenetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Neurogenetic Testing Basic Information
9.1.2 Quest Diagnostics Neurogenetic Testing Product Overview
9.1.3 Quest Diagnostics Neurogenetic Testing Product Market Performance
9.1.4 Quest Diagnostics Neurogenetic Testing SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Mayo Clinic
9.2.1 Mayo Clinic Neurogenetic Testing Basic Information
9.2.2 Mayo Clinic Neurogenetic Testing Product Overview
9.2.3 Mayo Clinic Neurogenetic Testing Product Market Performance
9.2.4 Quest Diagnostics Neurogenetic Testing SWOT Analysis
9.2.5 Mayo Clinic Business Overview
9.2.6 Mayo Clinic Recent Developments
9.3 GeneDx
9.3.1 GeneDx Neurogenetic Testing Basic Information
9.3.2 GeneDx Neurogenetic Testing Product Overview
9.3.3 GeneDx Neurogenetic Testing Product Market Performance
9.3.4 Quest Diagnostics Neurogenetic Testing SWOT Analysis
9.3.5 GeneDx Business Overview
9.3.6 GeneDx Recent Developments
9.4 Illumina
9.4.1 Illumina Neurogenetic Testing Basic Information
9.4.2 Illumina Neurogenetic Testing Product Overview
9.4.3 Illumina Neurogenetic Testing Product Market Performance
9.4.4 Illumina Business Overview
9.4.5 Illumina Recent Developments
9.5 Labcorp
9.5.1 Labcorp Neurogenetic Testing Basic Information
9.5.2 Labcorp Neurogenetic Testing Product Overview
9.5.3 Labcorp Neurogenetic Testing Product Market Performance
9.5.4 Labcorp Business Overview
9.5.5 Labcorp Recent Developments
9.6 Invitae
9.6.1 Invitae Neurogenetic Testing Basic Information
9.6.2 Invitae Neurogenetic Testing Product Overview
9.6.3 Invitae Neurogenetic Testing Product Market Performance
9.6.4 Invitae Business Overview
9.6.5 Invitae Recent Developments
9.7 MedGenome Labs
9.7.1 MedGenome Labs Neurogenetic Testing Basic Information
9.7.2 MedGenome Labs Neurogenetic Testing Product Overview
9.7.3 MedGenome Labs Neurogenetic Testing Product Market Performance
9.7.4 MedGenome Labs Business Overview
9.7.5 MedGenome Labs Recent Developments
9.8 Connecticut Children’s
9.8.1 Connecticut Children’s Neurogenetic Testing Basic Information
9.8.2 Connecticut Children’s Neurogenetic Testing Product Overview
9.8.3 Connecticut Children’s Neurogenetic Testing Product Market Performance
9.8.4 Connecticut Children’s Business Overview
9.8.5 Connecticut Children’s Recent Developments
9.9 CENTOGENE
9.9.1 CENTOGENE Neurogenetic Testing Basic Information
9.9.2 CENTOGENE Neurogenetic Testing Product Overview
9.9.3 CENTOGENE Neurogenetic Testing Product Market Performance
9.9.4 CENTOGENE Business Overview
9.9.5 CENTOGENE Recent Developments
9.10 Victorian Clinical Genetics Services
9.10.1 Victorian Clinical Genetics Services Neurogenetic Testing Basic Information
9.10.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
9.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Product Market Performance
9.10.4 Victorian Clinical Genetics Services Business Overview
9.10.5 Victorian Clinical Genetics Services Recent Developments
9.11 PacBio
9.11.1 PacBio Neurogenetic Testing Basic Information
9.11.2 PacBio Neurogenetic Testing Product Overview
9.11.3 PacBio Neurogenetic Testing Product Market Performance
9.11.4 PacBio Business Overview
9.11.5 PacBio Recent Developments
10 NEUROGENETIC TESTING REGIONAL MARKET FORECAST
10.1 Global Neurogenetic Testing Market Size Forecast
10.2 Global Neurogenetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurogenetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Neurogenetic Testing Market Size Forecast by Region
10.2.4 South America Neurogenetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurogenetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neurogenetic Testing Market Forecast by Type (2025-2030)
11.2 Global Neurogenetic Testing Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neurogenetic Testing
1.2 Key Market Segments
1.2.1 Neurogenetic Testing Segment by Type
1.2.2 Neurogenetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROGENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROGENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Neurogenetic Testing Revenue Market Share by Company (2019-2024)
3.2 Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Neurogenetic Testing Market Size Sites, Area Served, Product Type
3.4 Neurogenetic Testing Market Competitive Situation and Trends
3.4.1 Neurogenetic Testing Market Concentration Rate
3.4.2 Global 5 and 10 Largest Neurogenetic Testing Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 NEUROGENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Neurogenetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROGENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROGENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurogenetic Testing Market Size Market Share by Type (2019-2024)
6.3 Global Neurogenetic Testing Market Size Growth Rate by Type (2019-2024)
7 NEUROGENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurogenetic Testing Market Size (M USD) by Application (2019-2024)
7.3 Global Neurogenetic Testing Market Size Growth Rate by Application (2019-2024)
8 NEUROGENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Neurogenetic Testing Market Size by Region
8.1.1 Global Neurogenetic Testing Market Size by Region
8.1.2 Global Neurogenetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Neurogenetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurogenetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurogenetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurogenetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurogenetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Neurogenetic Testing Basic Information
9.1.2 Quest Diagnostics Neurogenetic Testing Product Overview
9.1.3 Quest Diagnostics Neurogenetic Testing Product Market Performance
9.1.4 Quest Diagnostics Neurogenetic Testing SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Mayo Clinic
9.2.1 Mayo Clinic Neurogenetic Testing Basic Information
9.2.2 Mayo Clinic Neurogenetic Testing Product Overview
9.2.3 Mayo Clinic Neurogenetic Testing Product Market Performance
9.2.4 Quest Diagnostics Neurogenetic Testing SWOT Analysis
9.2.5 Mayo Clinic Business Overview
9.2.6 Mayo Clinic Recent Developments
9.3 GeneDx
9.3.1 GeneDx Neurogenetic Testing Basic Information
9.3.2 GeneDx Neurogenetic Testing Product Overview
9.3.3 GeneDx Neurogenetic Testing Product Market Performance
9.3.4 Quest Diagnostics Neurogenetic Testing SWOT Analysis
9.3.5 GeneDx Business Overview
9.3.6 GeneDx Recent Developments
9.4 Illumina
9.4.1 Illumina Neurogenetic Testing Basic Information
9.4.2 Illumina Neurogenetic Testing Product Overview
9.4.3 Illumina Neurogenetic Testing Product Market Performance
9.4.4 Illumina Business Overview
9.4.5 Illumina Recent Developments
9.5 Labcorp
9.5.1 Labcorp Neurogenetic Testing Basic Information
9.5.2 Labcorp Neurogenetic Testing Product Overview
9.5.3 Labcorp Neurogenetic Testing Product Market Performance
9.5.4 Labcorp Business Overview
9.5.5 Labcorp Recent Developments
9.6 Invitae
9.6.1 Invitae Neurogenetic Testing Basic Information
9.6.2 Invitae Neurogenetic Testing Product Overview
9.6.3 Invitae Neurogenetic Testing Product Market Performance
9.6.4 Invitae Business Overview
9.6.5 Invitae Recent Developments
9.7 MedGenome Labs
9.7.1 MedGenome Labs Neurogenetic Testing Basic Information
9.7.2 MedGenome Labs Neurogenetic Testing Product Overview
9.7.3 MedGenome Labs Neurogenetic Testing Product Market Performance
9.7.4 MedGenome Labs Business Overview
9.7.5 MedGenome Labs Recent Developments
9.8 Connecticut Children’s
9.8.1 Connecticut Children’s Neurogenetic Testing Basic Information
9.8.2 Connecticut Children’s Neurogenetic Testing Product Overview
9.8.3 Connecticut Children’s Neurogenetic Testing Product Market Performance
9.8.4 Connecticut Children’s Business Overview
9.8.5 Connecticut Children’s Recent Developments
9.9 CENTOGENE
9.9.1 CENTOGENE Neurogenetic Testing Basic Information
9.9.2 CENTOGENE Neurogenetic Testing Product Overview
9.9.3 CENTOGENE Neurogenetic Testing Product Market Performance
9.9.4 CENTOGENE Business Overview
9.9.5 CENTOGENE Recent Developments
9.10 Victorian Clinical Genetics Services
9.10.1 Victorian Clinical Genetics Services Neurogenetic Testing Basic Information
9.10.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
9.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Product Market Performance
9.10.4 Victorian Clinical Genetics Services Business Overview
9.10.5 Victorian Clinical Genetics Services Recent Developments
9.11 PacBio
9.11.1 PacBio Neurogenetic Testing Basic Information
9.11.2 PacBio Neurogenetic Testing Product Overview
9.11.3 PacBio Neurogenetic Testing Product Market Performance
9.11.4 PacBio Business Overview
9.11.5 PacBio Recent Developments
10 NEUROGENETIC TESTING REGIONAL MARKET FORECAST
10.1 Global Neurogenetic Testing Market Size Forecast
10.2 Global Neurogenetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurogenetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Neurogenetic Testing Market Size Forecast by Region
10.2.4 South America Neurogenetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurogenetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neurogenetic Testing Market Forecast by Type (2025-2030)
11.2 Global Neurogenetic Testing Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurogenetic Testing Market Size Comparison by Region (M USD)
Table 5. Global Neurogenetic Testing Revenue (M USD) by Company (2019-2024)
Table 6. Global Neurogenetic Testing Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenetic Testing as of 2022)
Table 8. Company Neurogenetic Testing Market Size Sites and Area Served
Table 9. Company Neurogenetic Testing Product Type
Table 10. Global Neurogenetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Neurogenetic Testing
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Neurogenetic Testing Market Challenges
Table 18. Global Neurogenetic Testing Market Size by Type (M USD)
Table 19. Global Neurogenetic Testing Market Size (M USD) by Type (2019-2024)
Table 20. Global Neurogenetic Testing Market Size Share by Type (2019-2024)
Table 21. Global Neurogenetic Testing Market Size Growth Rate by Type (2019-2024)
Table 22. Global Neurogenetic Testing Market Size by Application
Table 23. Global Neurogenetic Testing Market Size by Application (2019-2024) & (M USD)
Table 24. Global Neurogenetic Testing Market Share by Application (2019-2024)
Table 25. Global Neurogenetic Testing Market Size Growth Rate by Application (2019-2024)
Table 26. Global Neurogenetic Testing Market Size by Region (2019-2024) & (M USD)
Table 27. Global Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Table 28. North America Neurogenetic Testing Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Neurogenetic Testing Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Neurogenetic Testing Market Size by Region (2019-2024) & (M USD)
Table 31. South America Neurogenetic Testing Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Neurogenetic Testing Market Size by Region (2019-2024) & (M USD)
Table 33. Quest Diagnostics Neurogenetic Testing Basic Information
Table 34. Quest Diagnostics Neurogenetic Testing Product Overview
Table 35. Quest Diagnostics Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Quest Diagnostics Neurogenetic Testing SWOT Analysis
Table 37. Quest Diagnostics Business Overview
Table 38. Quest Diagnostics Recent Developments
Table 39. Mayo Clinic Neurogenetic Testing Basic Information
Table 40. Mayo Clinic Neurogenetic Testing Product Overview
Table 41. Mayo Clinic Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Quest Diagnostics Neurogenetic Testing SWOT Analysis
Table 43. Mayo Clinic Business Overview
Table 44. Mayo Clinic Recent Developments
Table 45. GeneDx Neurogenetic Testing Basic Information
Table 46. GeneDx Neurogenetic Testing Product Overview
Table 47. GeneDx Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Quest Diagnostics Neurogenetic Testing SWOT Analysis
Table 49. GeneDx Business Overview
Table 50. GeneDx Recent Developments
Table 51. Illumina Neurogenetic Testing Basic Information
Table 52. Illumina Neurogenetic Testing Product Overview
Table 53. Illumina Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Illumina Business Overview
Table 55. Illumina Recent Developments
Table 56. Labcorp Neurogenetic Testing Basic Information
Table 57. Labcorp Neurogenetic Testing Product Overview
Table 58. Labcorp Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Labcorp Business Overview
Table 60. Labcorp Recent Developments
Table 61. Invitae Neurogenetic Testing Basic Information
Table 62. Invitae Neurogenetic Testing Product Overview
Table 63. Invitae Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Invitae Business Overview
Table 65. Invitae Recent Developments
Table 66. MedGenome Labs Neurogenetic Testing Basic Information
Table 67. MedGenome Labs Neurogenetic Testing Product Overview
Table 68. MedGenome Labs Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 69. MedGenome Labs Business Overview
Table 70. MedGenome Labs Recent Developments
Table 71. Connecticut Children’s Neurogenetic Testing Basic Information
Table 72. Connecticut Children’s Neurogenetic Testing Product Overview
Table 73. Connecticut Children’s Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Connecticut Children’s Business Overview
Table 75. Connecticut Children’s Recent Developments
Table 76. CENTOGENE Neurogenetic Testing Basic Information
Table 77. CENTOGENE Neurogenetic Testing Product Overview
Table 78. CENTOGENE Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 79. CENTOGENE Business Overview
Table 80. CENTOGENE Recent Developments
Table 81. Victorian Clinical Genetics Services Neurogenetic Testing Basic Information
Table 82. Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
Table 83. Victorian Clinical Genetics Services Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Victorian Clinical Genetics Services Business Overview
Table 85. Victorian Clinical Genetics Services Recent Developments
Table 86. PacBio Neurogenetic Testing Basic Information
Table 87. PacBio Neurogenetic Testing Product Overview
Table 88. PacBio Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 89. PacBio Business Overview
Table 90. PacBio Recent Developments
Table 91. Global Neurogenetic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 92. North America Neurogenetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Europe Neurogenetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 94. Asia Pacific Neurogenetic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 95. South America Neurogenetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Neurogenetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Global Neurogenetic Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 98. Global Neurogenetic Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurogenetic Testing Market Size Comparison by Region (M USD)
Table 5. Global Neurogenetic Testing Revenue (M USD) by Company (2019-2024)
Table 6. Global Neurogenetic Testing Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenetic Testing as of 2022)
Table 8. Company Neurogenetic Testing Market Size Sites and Area Served
Table 9. Company Neurogenetic Testing Product Type
Table 10. Global Neurogenetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Neurogenetic Testing
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Neurogenetic Testing Market Challenges
Table 18. Global Neurogenetic Testing Market Size by Type (M USD)
Table 19. Global Neurogenetic Testing Market Size (M USD) by Type (2019-2024)
Table 20. Global Neurogenetic Testing Market Size Share by Type (2019-2024)
Table 21. Global Neurogenetic Testing Market Size Growth Rate by Type (2019-2024)
Table 22. Global Neurogenetic Testing Market Size by Application
Table 23. Global Neurogenetic Testing Market Size by Application (2019-2024) & (M USD)
Table 24. Global Neurogenetic Testing Market Share by Application (2019-2024)
Table 25. Global Neurogenetic Testing Market Size Growth Rate by Application (2019-2024)
Table 26. Global Neurogenetic Testing Market Size by Region (2019-2024) & (M USD)
Table 27. Global Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Table 28. North America Neurogenetic Testing Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Neurogenetic Testing Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Neurogenetic Testing Market Size by Region (2019-2024) & (M USD)
Table 31. South America Neurogenetic Testing Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Neurogenetic Testing Market Size by Region (2019-2024) & (M USD)
Table 33. Quest Diagnostics Neurogenetic Testing Basic Information
Table 34. Quest Diagnostics Neurogenetic Testing Product Overview
Table 35. Quest Diagnostics Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Quest Diagnostics Neurogenetic Testing SWOT Analysis
Table 37. Quest Diagnostics Business Overview
Table 38. Quest Diagnostics Recent Developments
Table 39. Mayo Clinic Neurogenetic Testing Basic Information
Table 40. Mayo Clinic Neurogenetic Testing Product Overview
Table 41. Mayo Clinic Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Quest Diagnostics Neurogenetic Testing SWOT Analysis
Table 43. Mayo Clinic Business Overview
Table 44. Mayo Clinic Recent Developments
Table 45. GeneDx Neurogenetic Testing Basic Information
Table 46. GeneDx Neurogenetic Testing Product Overview
Table 47. GeneDx Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Quest Diagnostics Neurogenetic Testing SWOT Analysis
Table 49. GeneDx Business Overview
Table 50. GeneDx Recent Developments
Table 51. Illumina Neurogenetic Testing Basic Information
Table 52. Illumina Neurogenetic Testing Product Overview
Table 53. Illumina Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Illumina Business Overview
Table 55. Illumina Recent Developments
Table 56. Labcorp Neurogenetic Testing Basic Information
Table 57. Labcorp Neurogenetic Testing Product Overview
Table 58. Labcorp Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Labcorp Business Overview
Table 60. Labcorp Recent Developments
Table 61. Invitae Neurogenetic Testing Basic Information
Table 62. Invitae Neurogenetic Testing Product Overview
Table 63. Invitae Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Invitae Business Overview
Table 65. Invitae Recent Developments
Table 66. MedGenome Labs Neurogenetic Testing Basic Information
Table 67. MedGenome Labs Neurogenetic Testing Product Overview
Table 68. MedGenome Labs Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 69. MedGenome Labs Business Overview
Table 70. MedGenome Labs Recent Developments
Table 71. Connecticut Children’s Neurogenetic Testing Basic Information
Table 72. Connecticut Children’s Neurogenetic Testing Product Overview
Table 73. Connecticut Children’s Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Connecticut Children’s Business Overview
Table 75. Connecticut Children’s Recent Developments
Table 76. CENTOGENE Neurogenetic Testing Basic Information
Table 77. CENTOGENE Neurogenetic Testing Product Overview
Table 78. CENTOGENE Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 79. CENTOGENE Business Overview
Table 80. CENTOGENE Recent Developments
Table 81. Victorian Clinical Genetics Services Neurogenetic Testing Basic Information
Table 82. Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
Table 83. Victorian Clinical Genetics Services Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Victorian Clinical Genetics Services Business Overview
Table 85. Victorian Clinical Genetics Services Recent Developments
Table 86. PacBio Neurogenetic Testing Basic Information
Table 87. PacBio Neurogenetic Testing Product Overview
Table 88. PacBio Neurogenetic Testing Revenue (M USD) and Gross Margin (2019-2024)
Table 89. PacBio Business Overview
Table 90. PacBio Recent Developments
Table 91. Global Neurogenetic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 92. North America Neurogenetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Europe Neurogenetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 94. Asia Pacific Neurogenetic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 95. South America Neurogenetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Neurogenetic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Global Neurogenetic Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 98. Global Neurogenetic Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Neurogenetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurogenetic Testing Market Size (M USD), 2019-2030
Figure 5. Global Neurogenetic Testing Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Neurogenetic Testing Market Size by Country (M USD)
Figure 10. Global Neurogenetic Testing Revenue Share by Company in 2023
Figure 11. Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Neurogenetic Testing Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Neurogenetic Testing Market Share by Type
Figure 15. Market Size Share of Neurogenetic Testing by Type (2019-2024)
Figure 16. Market Size Market Share of Neurogenetic Testing by Type in 2022
Figure 17. Global Neurogenetic Testing Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Neurogenetic Testing Market Share by Application
Figure 20. Global Neurogenetic Testing Market Share by Application (2019-2024)
Figure 21. Global Neurogenetic Testing Market Share by Application in 2022
Figure 22. Global Neurogenetic Testing Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Figure 24. North America Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Neurogenetic Testing Market Size Market Share by Country in 2023
Figure 26. U.S. Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Neurogenetic Testing Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Neurogenetic Testing Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Neurogenetic Testing Market Size Market Share by Country in 2023
Figure 31. Germany Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Neurogenetic Testing Market Size Market Share by Region in 2023
Figure 38. China Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 44. South America Neurogenetic Testing Market Size Market Share by Country in 2023
Figure 45. Brazil Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Neurogenetic Testing Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Neurogenetic Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Neurogenetic Testing Market Share Forecast by Type (2025-2030)
Figure 57. Global Neurogenetic Testing Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Neurogenetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurogenetic Testing Market Size (M USD), 2019-2030
Figure 5. Global Neurogenetic Testing Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Neurogenetic Testing Market Size by Country (M USD)
Figure 10. Global Neurogenetic Testing Revenue Share by Company in 2023
Figure 11. Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Neurogenetic Testing Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Neurogenetic Testing Market Share by Type
Figure 15. Market Size Share of Neurogenetic Testing by Type (2019-2024)
Figure 16. Market Size Market Share of Neurogenetic Testing by Type in 2022
Figure 17. Global Neurogenetic Testing Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Neurogenetic Testing Market Share by Application
Figure 20. Global Neurogenetic Testing Market Share by Application (2019-2024)
Figure 21. Global Neurogenetic Testing Market Share by Application in 2022
Figure 22. Global Neurogenetic Testing Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Figure 24. North America Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Neurogenetic Testing Market Size Market Share by Country in 2023
Figure 26. U.S. Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Neurogenetic Testing Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Neurogenetic Testing Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Neurogenetic Testing Market Size Market Share by Country in 2023
Figure 31. Germany Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Neurogenetic Testing Market Size Market Share by Region in 2023
Figure 38. China Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 44. South America Neurogenetic Testing Market Size Market Share by Country in 2023
Figure 45. Brazil Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Neurogenetic Testing Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Neurogenetic Testing Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Neurogenetic Testing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Neurogenetic Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Neurogenetic Testing Market Share Forecast by Type (2025-2030)
Figure 57. Global Neurogenetic Testing Market Share Forecast by Application (2025-2030)
